Skip to content

Clinical trials

Active, not recruiting Carcinoma, Renal Cell trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Active, not recruiting Country / region: Israel Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20171
20192
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
AstraZeneca1
Eisai Inc.1
Exelixis1
IceCure Medical Ltd.1
National Cancer Institute (NCI)1
NeoTX Therapeutics Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell8
Carcinoma2
Carcinoma, Hepatocellular1
Endometrial Neoplasms1
Esophageal Neoplasms1
Esophageal Squamous Cell Carcinoma1
Kidney Neoplasms1
Melanoma1
Mesothelioma1
Neoplasm Metastasis1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.